These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 23826999)

  • 1. Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice.
    Hou Y; Ryu CH; Park KY; Kim SM; Jeong CH; Jeun SS
    Stem Cell Res Ther; 2013 Jul; 4(4):77. PubMed ID: 23826999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis.
    Wang D; Li SP; Fu JS; Bai L; Guo L
    Int J Dev Neurosci; 2016 Apr; 49():60-6. PubMed ID: 26827767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy of multiple sclerosis using interferon β-secreting human bone marrow mesenchymal stem cells.
    Ryu CH; Park KY; Hou Y; Jeong CH; Kim SM; Jeun SS
    Biomed Res Int; 2013; 2013():696738. PubMed ID: 23710456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
    Togha M; Jahanshahi M; Alizadeh L; Jahromi SR; Vakilzadeh G; Alipour B; Gorji A; Ghaemi A
    Mol Neurobiol; 2017 May; 54(4):2445-2457. PubMed ID: 26971291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose-derived mesenchymal stem cells ameliorates experimental autoimmune encephalomyelitis via modulation of Th1/Th17 and expansion of Th2/Treg responses.
    Zargarani S; Tavaf MJ; Soltanmohammadi A; Yazdanpanah E; Baharlou R; Yousefi B; Sadighimoghaddam B; Esmaeili SA; Haghmorad D
    Cell Biol Int; 2024 Aug; 48(8):1124-1137. PubMed ID: 38741520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon β-secreting mesenchymal stem cells combined with minocycline attenuate experimental autoimmune encephalomyelitis.
    Hou Y; Heon Ryu C; Jun JA; Kim SM; Jeong CH; Jeun SS
    J Neuroimmunol; 2014 Sep; 274(1-2):20-7. PubMed ID: 25005115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis.
    Yu JW; Li YH; Song GB; Yu JZ; Liu CY; Liu JC; Zhang HF; Yang WF; Wang Q; Yan YP; Xiao BG; Ma CG
    J Mol Neurosci; 2016 Dec; 60(4):486-497. PubMed ID: 27573128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human olfactory mesenchymal stromal cell transplantation ameliorates experimental autoimmune encephalomyelitis revealing an inhibitory role for IL16 on myelination.
    Lindsay SL; Molęda AM; MacLellan LM; Keh SM; McElroy DE; Linington C; Goodyear CS; Barnett SC
    Acta Neuropathol Commun; 2022 Jan; 10(1):12. PubMed ID: 35093166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE).
    Yousefi F; Ebtekar M; Soleimani M; Soudi S; Hashemi SM
    Int Immunopharmacol; 2013 Nov; 17(3):608-16. PubMed ID: 23973288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
    Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
    Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
    Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
    Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of methylprednisolone and minocycline synergistically improves experimental autoimmune encephalomyelitis in C57 BL/6 mice.
    Chen X; Pi R; Liu M; Ma X; Jiang Y; Liu Y; Mao X; Hu X
    J Neuroimmunol; 2010 Sep; 226(1-2):104-9. PubMed ID: 20538348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic neuroprotective effects of Fingolimod and mesenchymal stem cells (MSC) in experimental autoimmune encephalomyelitis.
    Kassis I; Ben-Zwi M; Petrou P; Halimi M; Karussis D
    Immunol Lett; 2021 May; 233():11-19. PubMed ID: 33676976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal injection of mesenchymal stem cells-conditioned media (MSCS-CM) treated monocyte can potentially alleviate motor defects in experimental autoimmune encephalomyelitis female mice; An original experimental study.
    Jalali Kondori B; Abdolmaleki A; Raei M; Ghorbani Alvanegh A; Esmaeili Gouvarchin Ghaleh H
    Transpl Immunol; 2024 Aug; 85():102067. PubMed ID: 38839021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.
    Lu Z; Hu X; Zhu C; Wang D; Zheng X; Liu Q
    J Neuroimmunol; 2009 Jan; 206(1-2):58-69. PubMed ID: 19081144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
    Luccarini I; Ballerini C; Biagioli T; Biamonte F; Bellucci A; Rosi MC; Grossi C; Massacesi L; Casamenti F
    Exp Neurol; 2008 May; 211(1):214-26. PubMed ID: 18346732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CNS disease diminishes the therapeutic functionality of bone marrow mesenchymal stem cells.
    Sargent A; Bai L; Shano G; Karl M; Garrison E; Ranasinghe L; Planchon SM; Cohen J; Miller RH
    Exp Neurol; 2017 Sep; 295():222-232. PubMed ID: 28602834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis.
    Constantin G; Marconi S; Rossi B; Angiari S; Calderan L; Anghileri E; Gini B; Bach SD; Martinello M; Bifari F; Galiè M; Turano E; Budui S; Sbarbati A; Krampera M; Bonetti B
    Stem Cells; 2009 Oct; 27(10):2624-35. PubMed ID: 19676124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of AD-MSC (adipose-derived mesenchymal stem cells) as a vehicle for IFN-β delivery in experimental autoimmune encephalomyelitis.
    Mohammadzadeh A; Pourfathollah AA; Shahrokhi S; Fallah A; Tahoori MT; Amari A; Forouzandeh M; Soleimani M
    Clin Immunol; 2016 Aug; 169():98-106. PubMed ID: 27373971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
    Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
    Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.